Cellular Biomedicine (NASDAQ:CBMG) acquires the exclusive rights to CD40LGVAX, a cancer therapeutic vaccine that has shown potential efficacy for the treatment on non-small cell lung cancer (NSCLC), ...
Administrators behind the revamping of Molecular and Cellular Biology did not have to wait long to gauge the popularity of their new programs, courses, and requirement changes, said Alexander F.
Promising anti-tumor activity reported for C-CAR031, a novel Glypican 3 (GPC3)-targeting cell therapy designed by AstraZeneca SHANGHAI, April 17, 2023 /PRNewswire/ -- Shanghai Cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results